Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants (Q28651397)

1

0 references

author name string

Charles Karamagi

2

0 references

Paul Waako

3

0 references

Sheila M Bird

5

0 references

language of work or name

English

0 references

publication date

24 November 2014

0 references

published in

BMJ Open

0 references

volume

4

0 references

issue

11

0 references

page(s)

e005869

0 references

cites work

Adverse drug reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Specific features of medicines safety and pharmacovigilance in Africa

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Methodologies for the detection of adverse drug reactions: comparison of hospital databases, chart review and spontaneous reporting

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Adverse events in hospitals: the patient's point of view.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Determinants of under-reporting of adverse drug reactions: a systematic review.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Adverse drug reactions reporting by physicians in Ibadan, Nigeria

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Under-reporting of adverse drug reactions : a systematic review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Is there still a role for spontaneous reporting of adverse drug reactions?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

The cost of adverse drug reactions

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Patients' and physicians' attitudes regarding the disclosure of medical errors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Attitudes to adverse drug reactions and their reporting among medical practitioners.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Attitudes to adverse drug reaction reporting in the Northern Region

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

3 June 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

Africa struggles to improve drug safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

Drug reporting may be mandatory for doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005869

Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244492

Attitudes to adverse drug reaction reporting

27 November 2018

1 reference

12 December 2020

Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes

1 reference

12 December 2020

Spontaneous reporting of adverse drug reactions: who reports and what?

1 reference

12 December 2020

Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital

1 reference

12 December 2020

Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™

1 reference

12 December 2020

Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions

1 reference

12 December 2020

Influence of physicians' attitudes on reporting adverse drug events: a case-control study

1 reference

12 December 2020

Adverse drug reactions in a south Indian hospital--their severity and cost involved

1 reference

12 December 2020